Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The 2-step surgery effectively treats stable follicular vitiligo with high patient satisfaction and no major complications.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Melitane 5% and hair supplements improved hair color in a 14-year-old with early graying.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Generalized vitiligo in Chinese patients is linked to other autoimmune diseases, especially in familial cases.

Transplanting cultured skin sheets improved acne scars in four patients.

Certain gene variations and different levels of BDNF and CRH hormones are linked to vitiligo.

Vitiligo often starts young, is linked to family history and stress, and requires comprehensive care including psychological support.

New treatments and drugs show promise for improving skin pigmentation and regeneration.

Lasers have become precise tools in skin treatment and diagnosis, with ongoing advancements improving their effectiveness.

CD200 is not a reliable marker for identifying stem cells in all skin types.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

Trichoscopy helps distinguish between scalp Discoid Lupus Erythematosus and Lichen Planopilaris for accurate diagnosis and treatment.

Trichoscopy helps tell apart Frontal Fibrosing Alopecia and Lichen planopilaris by showing different hair and scalp features.

Low-level light therapy can promote hair growth by stimulating cell interactions in hair follicles.

Combining camouflage with psychotherapy improves quality of life for vitiligo patients.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Premature hair graying is caused by genetics, stress, and lifestyle, and affects mental health.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Scientists successfully regenerated functional hair follicles using specific stem cells and mesenchymal cells.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Targeting mitochondria can improve skin health and slow aging.

These new skin treatments are safer and more effective with minimal side effects.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

The new technique effectively treats hairline vitiligo with repigmentation and hair regrowth.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.